Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: A prospective, quantified electroencephalography study

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Koziarska, Dorota ^a   Wunsch, Ewa ^a   Milkiewicz, Małgorzata ^a   Wójcicki, Maciej ^b   Nowacki, Przemysław ^a   Milkiewicz, Piotr ^a,b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Electroencephalography; Frequency analysis; Hepatic encephalopathy; Liver cirrhosis; Mini mental state examination

Indexed keywords

ALBUMIN; AMMONIA; BILIRUBIN;

ADULT; AGED; ALPHA RHYTHM; AREA UNDER THE CURVE; ARTICLE; BETA RHYTHM; CHILD PUGH SCORE; COMPREHENSION; COMPULSION; CORRELATION ANALYSIS; DELTA RHYTHM; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEMALE; FREQUENCY ANALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PREDICTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPATIAL ORIENTATION; TASK PERFORMANCE; THETA RHYTHM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AREA UNDER CURVE; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; QUESTIONNAIRES; ROC CURVE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84879831433     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-107     Document Type: Article

References (39)

1. Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003, 48:1622-1626. 10.1023/A:1024784327783, 12924658.
2. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodes J. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999, 30:890-895. 10.1016/S0168-8278(99)80144-5, 10365817.
3. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Patology 2002, 35:716-721.
4. Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Patology 2009, 50:2014-2021.
5. Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY. Review article: the design of clinical trials in hepatic encephalopathy-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011, 33:739-747. 10.1111/j.1365-2036.2011.04590.x, 21306407.
6. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Patology 2004, 39:739-745.
7. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001, 96:2718-2723.
8. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004, 19:253-267.
9. Jover R, Company L, Gutierrez A, Zapater P, Perez-Serra J, Girona E, Aparicio JR, Perez-Mateo M. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Am J Gastroenterol 2003, 98:1599-1604. 10.1111/j.1572-0241.2003.07528.x, 12873585.
10. Kramer L, Bauer E, Gendo A, Funk G, Madl C, Pidlich J, Gangl A. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2002, 97:162-166. 10.1111/j.1572-0241.2002.05441.x, 11808942.
11. Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, Cammalleri L, Pennisi G, Rampello L. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci 2008, 53:3018-3025. 10.1007/s10620-008-0238-6, 18357530.
12. Meyer T, Eshelman A, Abouljoud M. Neuropsychological changes in a large sample of liver transplant candidates. Transplant Proc 2006, 38:3559-3560. 10.1016/j.transproceed.2006.10.050, 17175330.
13. Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Am J Gastroenterol 2003, 98:1395-1399. 10.1111/j.1572-0241.2003.07466.x, 12818287.
14. Folstein MF, Folstein SE, McHugh PR. " Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6, 1202204.
15. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993, 269:2386-2391. 10.1001/jama.1993.03500180078038, 8479064.
16. Child CG, Turcotte JG. Surgery and portal hypertension. Jor Probl Clin Surg 1964, 1:1-85.
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. J Surg 1973, 60:646-649.
18. Summerskill WH, Parsons-Smith BG, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet 1957, 273:867-871.
19. Amodio P, Del PF, Petteno E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 2001, 35:37-45. 10.1016/S0168-8278(01)00129-5, 11495040.
20. Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, Angeli P, Gatta A. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 2008, 49:346-353. 10.1016/j.jhep.2008.04.022, 18602716.
21. Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 1978, 23:398-406. 10.1007/BF01072921, 354373.
22. Kircheis G, Fleig WE, Gortelmeyer R, Grafe S, Haussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol 2007, 47:642-650. 10.1016/j.jhep.2007.05.019, 17869373.
23. Bajaj JS. Current and future diagnosis of hepatic encephalopathy. Metab Brain Dis 2010, 25:107-110. 10.1007/s11011-010-9176-z, 20213105.
24. Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, Ubiali E, Amodio P. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009, 29:789-796. 10.1111/j.1478-3231.2009.02030.x, 19638107.
25. Montagnese S, Amodio P, Morgan MY. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis 2004, 19:281-312.
26. Amodio P, Pellegrini A, Ubiali E, Mathy I, Piccolo FD, Orsato R, Gatta A, Guerit JM. The EEG assessment of low-grade hepatic encephalopathy: comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clin Neurophysiol 2006, 117:2243-2251. 10.1016/j.clinph.2006.06.714, 16931145.
27. Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009, 29:629-635. 10.1111/j.1478-3231.2009.02009.x, 19302444.
28. Montagnese S, Schiff S, De RM, Crossey MM, Amodio P, Taylor-Robinson SD. Neuropsychological tools in hepatology: a survival guide for the clinician. J Viral Hepat 2012, 19:307-315. 10.1111/j.1365-2893.2012.01592.x, 22497809.
29. Loguercio C, Del Vecchio-Blanco C, Coltorti M. Psychometric tests and " latent" portal-systemic encephalopathy. Br J Clin Pract 1984, 38:407-411.
30. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007, 52:3259-3265. 10.1007/s10620-006-9687-y, 17393330.
31. Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis 2011, 26:281-289. 10.1007/s11011-011-9260-z, 21870121.
32. Montagnese S, Schiff S, Turco M, Bonato CA, Ridola L, Gatta A, Nousbaum JB, Riggio O, Merkel C, Amodio P. Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy. Dig Liver Dis 2012, 44:957-960. 10.1016/j.dld.2012.06.010, 22819289.
33. Randolph C, Tierney MC, Mohr E, Chase TN. The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998, 20:310-319. 10.1076/jcen.20.3.310.823, 9845158.
34. Sood GK, Sarin SK, Mahaptra J, Broor SL. Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol 1989, 84:156-159.
35. Weissenborn K, Ruckert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998, 28:646-653.
36. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001, 34:768-773.
37. Haussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008, 57:1156-1165. 10.1136/gut.2007.122176, 18628377.
38. Blei AT, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol 2001, 96:1968-1976. 10.1111/j.1572-0241.2001.03964.x, 11467622.
39. Weissenborn K, Giewekemeyer K, Heidenreich S, Bokemeyer M, Berding G, Ahl B. Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 2005, 20:359-367. 10.1007/s11011-005-7919-z, 16382346.